108620002: Montelukast sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Leukotriene receptor antagonist\Montelukast sodium (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Leukotriene receptor antagonist\Montelukast sodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

173154010 Montelukast sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

602807019 Montelukast sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

826271000172119 montélukast sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Montelukast sodium (substance)	Is a	Product containing montelukast (medicinal product)	false	Inferred relationship	Some
Montelukast sodium (substance)	Is a	Montelukast	false	Inferred relationship	Some
Montelukast sodium (substance)	Is a	Montelukast (substance)	false	Inferred relationship	Some
Montelukast sodium (substance)	Is a	Montelukast agent	false	Inferred relationship	Some
Montelukast sodium (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Leukotriene receptor antagonist (disposition)	true	Inferred relationship	Some
Montelukast sodium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Montelukast (substance)	true	Inferred relationship	Some
Montelukast sodium (substance)	Is a	Leukotriene receptor antagonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Montelukast sodium 10mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some
Montelukast sodium 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some
Montelukast sodium 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some
Montelukast (as montelukast sodium) 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some
Montelukast sodium 4mg oral granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some
Montelukast (as montelukast sodium) 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast (as montelukast sodium) 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Montelukast sodium 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Montelukast sodium (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173154010	Montelukast sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
602807019	Montelukast sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
826271000172119	montélukast sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module